Pictet Asset Management (UK)’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Pictet Asset Management (UK)’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$81.6M	Buy	840,585 +75,564	+10%	+$6.13M	0.09%	258
2021 Q1	$52.3M	Buy	765,021 +357,222	+88%	+$28.9M	0.06%	319
2020 Q4	$35M	Buy	407,799 +201,943	+98%	+$17.1M	0.05%	377
2020 Q3	$13.4M	Buy	205,856 +695	+0.3%	+$45.5K	0.02%	498
2020 Q2	$15M	Buy	205,161 +58,403	+40%	+$3.11M	0.03%	442
2020 Q1	$4.99M	Sell	146,758 -192,794	-57%	-$8.82M	0.01%	640
2019 Q4	$18.5M	Buy	+339,552	New	+$16.8M	0.03%	464
2018 Q3	–	Sell	-570,786	Closed	-$22.6M	–	991
2018 Q2	$22.6M	Sell	570,786 -24,432	-4%	-$775K	0.05%	371
2018 Q1	$15.3M	Buy	595,218 +276,307	+87%	+$8.26M	0.04%	426
2017 Q4	$8.6M	Buy	+318,911	New	+$8.78M	0.02%	537

Other funds holding BHVN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Pictet Asset Management (UK)'s BHVN Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Biohaven Pharmaceutical Holding Company Ltd. (BHVN) stake by 9.9% in Q2 2021, buying an estimated $6.13M and bringing the position to 840,585 shares worth $81.6M. The position accounts for 0.09% of the portfolio, ranked #258.

Pictet Asset Management (UK) first reported a position in BHVN in Q4 2017 and has held it in 10 quarters since. 223 funds tracked by Wall St. Rank hold BHVN as of Q2 2021.

Pictet Asset Management (UK) held 840,585 shares of Biohaven Pharmaceutical Holding Company Ltd. worth $81.6M as of Q2 2021.
Pictet Asset Management (UK) bought 75,564 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2021, an estimated $6.13M.
Biohaven Pharmaceutical Holding Company Ltd. made up 0.09% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #258 holding.
Pictet Asset Management (UK) first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2017 and has held it in 10 quarters since.
223 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.